PKM2 has been identified as a critical regulator in HCC progression, with clinical analyses of extensive HCC tissue samples revealing a strong correlation between PKM2 expression levels, tumor aggressiveness, and immune cell infiltration (41). Here, PKM is linked to neoplasm.